Osimertinib in Indian patients with T790M-positive advanced nonsmall cell lung cancer

por Noronha, Vanita, Majumdar, Swaratika, Joshi, Amit, Patil, Vijay, Trivedi, Vaishakhi, Chougule, Anuradha, Prabhash, Kumar
Publicado 2017

The Importance of Brain Metastasis in EGFR Mutation Positive NSCLC Patients

por Noronha, Vanita, Joshi, Amit, Gokarn, Anant, Sharma, Vibhor, Patil, Vijay, Janu, Amit, Purandare, Nilendu, Chougule, Anuradha, Jambhekar, Nirmala, Prabhash, Kumar
Publicado 2014

Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysis

por Kate, Shruti, Chougule, Anuradha, Joshi, Amit, Noronha, Vanita, Patil, Vijay, Dusane, Rohit, Solanki, Leena, Tiwrekar, Priyanka, Trivedi, Vaishakhi, Prabhash, Kumar
Publicado 2019

ROS1 mutation non-small cell lung cancer—access to optimal treatment and outcomes

por Joshi, Amit, Pande, Nikhil, Noronha, Vanita, Patil, Vijay, Kumar, Rajiv, Chougule, Anuradha, Trivedi, Vaishakhi, Janu, Amit, Mahajan, Abhishek, Prabhash, Kumar
Publicado 2019

Third-line therapy in the epidermal growth factor receptor mutation-positive advanced nonsmall-cell lung cancer

por Noronha, Vanita, Pande, Nikhil, Joshi, Amit, Patil, Vijay, Trivedi, Vaishakhi, Chougule, Anuradha, Janu, Amit, Mahajan, Abhishek, Talreja, Vikas, Prabhash, Kumar
Publicado 2020

EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?

por Joshi, Amit, Zanwar, Saurabh, Noronha, Vanita, Patil, Vijay M, Chougule, Anuradha, Kumar, Rajiv, Janu, Amit, Mahajan, Abhishek, Kapoor, Akhil, Prabhash, Kumar
Publicado 2017

EGFR Mutations in Indian Lung Cancer Patients: Clinical Correlation and Outcome to EGFR Targeted Therapy

por Noronha, Vanita, Prabhash, Kumar, Thavamani, Abhishek, Chougule, Anuradha, Purandare, Nilendu, Joshi, Amit, Sharma, Rashmi, Desai, Saral, Jambekar, Nirmala, Dutt, Amit, Mulherkar, Rita
Publicado 2013

Frequency of EGFR Mutations in 907 Lung Adenocarcioma Patients of Indian Ethnicity

por Chougule, Anuradha, Prabhash, Kumar, Noronha, Vanita, Joshi, Amit, Thavamani, Abhishek, Chandrani, Pratik, Upadhyay, Pawan, Utture, Sagarika, Desai, Saral, Jambhekar, Nirmala, Dutt, Amit
Publicado 2013

Comprehensive Development and Implementation of Good Laboratory Practice for NGS Based Targeted Panel on Solid Tumor FFPE Tissues in Diagnostics

por Chougule, Anuradha, Jagtap, Vinita, Nikam, Ankita, Kale, Shrutikaa, Nambiar, Kavya, Bagayatkar, Priyanka, Chandrani, Pratik, Kaushal, Rajiv, Noronha, Vanita, Patil, Vijay, Banavali, Shripad, Prabhash, Kumar
Publicado 2022

Treatment pattern and outcomes in de novo T790M-mutated non-small cell lung cancer

por Panda, Goutam Santosh, Noronha, Vanita, Shah, Darshit, John, George, Chougule, Anuradha, Patil, Vijay, Kumar, Rajiv, Menon, Nandini, Singh, Ajay, Chandrani, Pratik, Mahajan, Abhishek, Prabhash, Kumar
Publicado 2022

Integrated proteomics and phosphoproteomics revealed druggable kinases in neoadjuvant chemotherapy resistant tongue cancer

por George, Irene A., Sathe, Gajanan, Ghose, Vivek, Chougule, Anuradha, Chandrani, Pratik, Patil, Vijay, Noronha, Vanita, Venkataramanan, R., Limaye, Sewanti, Pandey, Akhilesh, Prabhash, Kumar, Kumar, Prashant
Publicado 2022

Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study

por Pasquier, Eddy, André, Nicolas, Street, Janine, Chougule, Anuradha, Rekhi, Bharat, Ghosh, Jaya, Philip, Deepa S.J., Meurer, Marie, MacKenzie, Karen L., Kavallaris, Maria, Banavali, Shripad D.
Publicado 2016

ALK Positive Lung Cancer: Clinical Profile, Practice and Outcomes in a Developing Country

por Noronha, Vanita, Ramaswamy, Anant, Patil, Vijay M, Joshi, Amit, Chougule, Anuradha, Kane, Subhadha, Kumar, Rajiv, Sahu, Arvind, Doshi, Vipul, Nayak, Lingaraj, Mahajan, Abhishek, Janu, Amit, Prabhash, Kumar
Publicado 2016

An observational study to evaluate factors predicting survival in patients of non-small cell lung cancer with poor performance status in resource-constrained settings

por Kapoor, Akhil, Noronha, Vanita, Joshi, Amit, Patil, Vijay M, Menon, Nandini, Bollam, Rajesh, Talreja, Vikas, Goud, Supriya, More, Sucheta, Solanki, Leena, Shah, Srushti, Chougule, Anuradha, Mahajan, Abhishek, Prabhash, Kumar
Publicado 2021

Clinical Profile, Practice Pattern, and Outcomes With First-Line Therapy in ALK-Positive Lung Cancer: Real-World Data From Resource-Constrained Settings

por Kapoor, Akhil, Noronha, Vanita, Patil, Vijay, Menon, Nandini, Joshi, Amit, Kumar, Amit, Singh, Ajay Kumar, Mahajan, Abhishek, Janu, Amit, Kumar, Rajiv, Pai, Trupti, Chougule, Anuradha, Shetty, Omshree, Prabhash, Kumar
Publicado 2022

Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell l...

por Patil, Vijay, Joshi, Amit, Noronha, Vanita, Agarwala, Vivek, Chougule, Anuradha, Kanan, Sadhana, Bhattacharjee, Atanu, Chandrasekharan, Arun, Pande, Nikhil, Simha, Vijai, Goud, Supriya, More, Sucheta, Kumar, Rajiv, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar
Publicado 2019

Impact of exon 19 versus exon 21 EGFR-activating mutation on outcomes with upfront pemetrexed–carboplatin chemotherapy

por Noronha, Vanita, Patil, Vijay, Joshi, Amit, Chougule, Anuradha, Bhattacharjee, Atanu, Kumar, Rajiv, More, Sucheta, Goud, Supriya, Karpe, Ashay, Ramaswamy, Anant, Pande, Nikhil, Chandrasekharan, Arun, Goel, Alok, Talreja, Vikas, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar
Publicado 2017

Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation?

por Joshi, Amit, Patil, Vijay, Noronha, Vanita, Chougule, Anuradha, Bhattacharjee, Atanu, Kumar, Rajiv, Goud, Supriya, More, Sucheta, Ramaswamy, Anant, Karpe, Ashay, Pande, Nikhil, Chandrasekharan, Arun, Goel, Alok, Talreja, Vikas, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar
Publicado 2018

Efficacy of Second-Line Pemetrexed-Carboplatin in EGFR-Activating Mutation-Positive NSCLC: Does Exon 19 Deletion Differ from Exon 21 Mutation?

por Joshi, Amit, Noronha, Vanita, Patil, Vijay M., Chougule, Anuradha, Bhattacharjee, Atanu, Kumar, Rajiv, Goud, Supriya, More, Sucheta, Ramaswamy, Anant, Karpe, Ashay, Pande, Nikhil, Chandrasekharan, Arun, Goel, Alok, Talreja, Vikas, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar
Publicado 2017

Epidermal Growth Factor Receptor Mutational Status and Brain Metastases in Non–Small-Cell Lung Cancer

por Bhatt, Vijaya Raj, D’Souza, Sanyo P., Smith, Lynette M., Cushman-Vokoun, Allison M., Noronha, Vanita, Verma, Vivek, Joshi, Amit, Chougule, Anuradha, Jambhekar, Nirmala, Kessinger, Anne, Marr, Alissa, Patil, Vijay, Banavali, Sripad D., Ganti, Apar Kishor, Prabhash, Kumar
Publicado 2016